Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Ruotian Wang"'
Autor:
Xiaoru Tian, Xingsheng Liu, Kai Wang, Ruotian Wang, Yuanbo Li, Kun Qian, Tengteng Wang, Xin Zhao, Lei Liu, Pei Long Zhang, Yuanyuan Xiong, Jinqiu Rui, Rongrong Chen, Yi Zhang
Publikováno v:
Thoracic Cancer, Vol 15, Iss 10, Pp 797-807 (2024)
Abstract Background Circulating tumor DNA (ctDNA) has emerged as a potential novel biomarker to predict molecular residual disease (MRD) in lung cancer after definitive treatment. Herein, we investigated the value of ctDNA in prognosing risk of relap
Externí odkaz:
https://doaj.org/article/5adab23eaf8949089dc5c604fa28d72c
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The circadian clock and endoplasmic reticulum stress signaling play important roles in oncogenesis and development of cancer. Sleep disorders have been linked to an elevated risk of mortality in general populations. Nonetheless, t
Externí odkaz:
https://doaj.org/article/920d375789294b508f6f855920a5b31c
Publikováno v:
Chinese Journal of Lung Cancer, Vol 25, Iss 12, Pp 843-851 (2022)
Background and objective Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) capable of overcoming non-small cell lung cancer (NSCLC) with EGFR T790M mutation. Although the addition of bevacizumab
Externí odkaz:
https://doaj.org/article/9cebbb8854944d7fba4e4901df379f5a
Autor:
Yankun Zhu, Mingyao Meng, Zongliu Hou, Wenju Wang, Lin Li, Aoran Guan, Ruotian Wang, Weiwei Tang, Fang Yang, Yiyi Zhao, Hui Gao, Hui Xie, Ruhong Li, Jing Tan
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundExpansion and activation of cytotoxic T lymphocytes (CTLs) in vitro represents a promising immunotherapeutic strategy, and CTLs can be primed by dendritic cells (DCs) loaded with tumor-associated antigens (TAAs) transformed by recombinant a
Externí odkaz:
https://doaj.org/article/5326e7d8324a4d7d955e9b190720779b
Publikováno v:
Journal of Interventional Medicine, Vol 3, Iss 4, Pp 180-183 (2020)
Objectives: To retrospectively analyze the clinical results of the treatment of pulmonary multifocal adenocarcinoma presenting as ground glass opacity (GGO) by surgery and thermal ablation. Methods: 87 GGO-type pulmonary adenocarcinomas of 48 patient
Externí odkaz:
https://doaj.org/article/bc1729e2bf164e2c9b34624423891b8a
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor cells use metabolic reprogramming to keep up with the need for bioenergy, biosynthesis, and oxidation balance needed for rapid tumor division. This phenomenon is considered a marker of tumors, including colon cancer (CRC). As an important pathw
Externí odkaz:
https://doaj.org/article/6685f4f4ad7c42389a26ab753af7d21b
Publikováno v:
Chinese Journal of Lung Cancer, Vol 23, Iss 6, Pp 466-471 (2020)
Background and objective As a new technique developed in recent years, endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has the advantages of simple operation, minimal invasive, high accuracy, safety and repeatability. It
Externí odkaz:
https://doaj.org/article/4eed9f1217124171bf6cd938372d3ed3
Publikováno v:
Thoracic Cancer, Vol 11, Iss 5, Pp 1265-1270 (2020)
Background IBM Watson for Oncology (WFO) provides physicians with evidence‐based treatment options. This study was designed to explore the concordance of the suggested therapeutic regimen for advanced non‐small cell lung (NSCLC) cancer patients b
Externí odkaz:
https://doaj.org/article/c7665365cc95408296a26007ebbcac46
Publikováno v:
Chinese Journal of Lung Cancer, Vol 23, Iss 5, Pp 333-336 (2020)
Background and objective Lung cancer is one of the most dangerous diseases to human health, with high morbidity and mortality. It can be cured by surgery at early stage, therefore, the early detection and early treatment of lung cancer are especially
Externí odkaz:
https://doaj.org/article/6a12cb2dcfa54668a1e352c6cac4cacf
Autor:
Xiao Li, Haodong Zhou, Wenwen Huang, Xuejuan Wang, Mingyao Meng, Zongliu Hou, Liwei Liao, Weiwei Tang, Yanhua Xie, Ruotian Wang, Haidong Yu, Liqiong Wang, Huirong Zhu, Wenju Wang, Jing Tan, Ruhong Li
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 1, Pp n/a-n/a (2022)
Abstract Objectives Even though postoperative chemotherapy can eliminate residual tumor cells in patients with colorectal cancer (CRC), severe adversity, weakened immunity and drug resistance are still problems. Adjuvant cytokine‐induced killer (CI
Externí odkaz:
https://doaj.org/article/9de427c2acf74615baf132cbf7001f4d